InflaRx on large white.jpg
InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients
April 04, 2023 14:55 ET | InflaRx N.V.
Vilobelimab is the first authorized drug to control complement factor C5a, a protein that plays an important and often harmful role in the body's immune responseFDA granted EUA based on Phase III...
Lucira_COVID-19_&_Flu_Home_Test_packaging_and_device
Lucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale Process
March 28, 2023 08:05 ET | Lucira Health Inc.
Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to access...
Image w slogan.png
Totally Safe Air Expands Business Offerings to Include AirAnswers® Air Diagnostic™ System
March 16, 2023 18:58 ET | AirAnswers Inc
NORTH CHICAGO, Ill., March 16, 2023 (GLOBE NEWSWIRE) -- AirAnswers® has announced a new partnership today with Totally Safe Air. AirAnswers and Totally Safe Air join forces to identify and eliminate...
ExeVir logo.png
ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19
March 13, 2023 05:00 ET | ExeVir Bio
ExeVir Bio and VIB-UGent’s bioRxiv pre-print reports on S2-binding camelid single-domain antibody-based drug, XVR013, that targets the Achilles’ heel in the SARS-CoV-2 viral spikeFocus on protecting...
Virufy
UPDATE: THE COVID-19 DETECTION FOUNDATION (dba VIRUFY) and BARDA ANNOUNCE CONTRACT to RESEARCH & DEVELOP COVID-19 SCREENING THROUGH AI/MACHINE LEARNING
March 08, 2023 09:16 ET | Virufy
SAN FRANCISCO, March 08, 2023 (GLOBE NEWSWIRE) -- The COVID-19 Detection Foundation (dba Virufy), a 501(c)(3) non-profit research organization (https://virufy.org) developing a smartphone app for...
4 Pack
eMed launches first-of-its-kind eMed® Urgent Care Telehealth Kit™, enabling access to same-day clinical evaluations and prescription medications for four common illnesses
March 03, 2023 11:09 ET | eMed
MIAMI, March 03, 2023 (GLOBE NEWSWIRE) -- eMed, the leader in at-home, test-to-treat telehealth kits, today announced the first-of-its-kind eMed® Urgent Care Telehealth Kit™. Powered by eMed's...
Image w slogan.png
New Technology Can Now Test for Airborne COVID and Several Strains of the Common Flu
March 01, 2023 23:35 ET | AirAnswers Inc
NORTH CHICAGO, Ill., March 01, 2023 (GLOBE NEWSWIRE) -- AirAnswers, the leader in air sampling and testing technology, is expanding their test offering to include a panel of airborne viruses...
Logos-CCLF_Full_Identity_French_colour_RGB.png
MISE À JOUR -- La Fondation pour l’alphabétisation des enfants canadiens lance une exposition virtuelle d’histoires de pandémie racontées par des enfants TORONTO, 01 mars 2023 (GLOBE NEWSWIRE) -- La Fondation pour l’alphabétisation des enfants canadiens lance une galerie virtuelle publique présentant des histoires et des œuvres artistiques racontées...
Logos-CCLF_Full_Identity_English_colour_RGB.png
UPDATE -- The Canadian Children’s Literacy Foundation to launch a digital exhibition of children’s pandemic stories
March 01, 2023 08:13 ET | Canadian Children’s Literacy Foundation
TORONTO, March 01, 2023 (GLOBE NEWSWIRE) -- The Canadian Children’s Literacy Foundation is launching an online public gallery featuring stories and art by children from across Canada about their...
Logos-CCLF_Full_Identity_French_colour_RGB.png
La Fondation pour l’alphabétisation des enfants canadiens lance une exposition virtuelle d’histoires de pandémie racontées par des enfants TORONTO, 28 févr. 2023 (GLOBE NEWSWIRE) -- La Fondation pour l’alphabétisation des enfants canadiens lance une galerie virtuelle publique présentant des histoires et des œuvres artistiques...